![Calveley Peter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Calveley Peter is currently the Chief Operating Officer at Westlake Biopartners LLC since 2021.
Prior to this, he worked as a Managing Director at Leerink Partners LLC from 2010 to 2019.
Mr. Peter completed his undergraduate degree from Queen's University in 2001 and received an MBA from UCLA Anderson School of Management in 2007.
Aktive Positionen von Calveley Peter
| Unternehmen | Position | Beginn |
|---|---|---|
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Geschäftsführer | 01.02.2021 |
Ehemalige bekannte Positionen von Calveley Peter
| Unternehmen | Position | Ende |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Direktor/Vorstandsmitglied | 30.09.2019 |
Ausbildung von Calveley Peter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
99
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westlake Biopartners LLC
Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Finance |
